SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Medicenna Therapeutics Q2 FY27 net loss narrows 18% year over year to $4 million

Medicenna Therapeutics Q2 FY27 net loss narrows 18% year over year to $4 million Medicenna Thera

Related stories